CDKN2A and head and neck squamous cell carcinoma: For the non-OP HNSCC cohort, we also detected a longer rwOS for the p16+ group compared to the p16− group similar to OPSCC (34 vs. 17 months, HR 0.551, p = 0.0001, Table 3 and Figure 6B).